• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

New Study: Challenging Psychedelic Trips Lead to Positive Mental Health

Microdose NewsDesk by Microdose NewsDesk
March 10, 2023
in Science
Reading Time: 1 min read
A A
Tripping Without The Trip: Non-Hallucinogenic Psychedelics

A new study suggests that challenging and mystical psychedelic experiences may be connected to improved mental health outcomes.

The research was published in the Journal of Affective Disorders and reviewed survey data from almost 1,000 respondents regarding their personal experiences with psychedelics.

As reported in this article by the Ohio State News, the data suggested a connection between the intensity of mystical or insightful psychedelic experiences – and reported improvements in mental health like anxiety and depression symptoms.

The analysis also showed that challenging experiences during psychedelic trips can potentially lead to beneficial mental health results after the difficult period has passed.  These patterns were observed across all psychedelic substances, including 5-MeO-DMT, Ayahuasca, LSD, mescaline, psilocybin, and peyote

[bsa_pro_ad_space id=2]
ADVERTISEMENT

See the study here

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

Lasix Secure Online Order

.

For more like this, check out New Study Shows SSRIs Ineffective Compared to Psychedelics and Can LSD Make You Smarter? New Study Shows Positive Results

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: science
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Death, Hope, and The Psychedelic Experience

Death, Hope, and The Psychedelic Experience

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.